XBiotech Inc.

NASDAQ:XBIT

Biotechnology

Healthcare
$1.68 -0.84%

-$0.02 today

Market cap
$51.22M
Beta
0.84
P/E (TTM)
-1.8
EPS (TTM)
-$1.32
52W Low $2.09High $3.61

Volume 0.05M

Average 0.03M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$55.69M

FY 2025 · Annual

Net Income

-$45.54M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue18.39M4.01M000
Cost of Revenue5.82M651K001.69M
Gross Profit12.57M3.36M00(1.69M)
Gross Margin68.4%83.8%———
Research & Development28.27M31.54M32.85M37.76M47.39M
Selling, General & Admin9.39M6.31M4.66M4.71M8.3M
Operating Expenses37.66M37.85M37.51M42.47M54M
Depreciation & Amortization2.65M2.61M1.74M1.75M1.69M
EBITDA(22.81M)(30.97M)(22.57M)(36.01M)(43.53M)
EBITDA Margin-124.0%-772.4%———
Operating Income(25.08M)(34.49M)(37.51M)(42.47M)(55.69M)
Operating Margin-136.4%-860.1%———
Interest Income467K3.82M10.42M9.81M5.68M
Interest Expense000807K88K
Other Income / Expenses(376K)902K13.2M3.91M10.38M
Income Before Tax(25.46M)(33.59M)(24.31M)(38.56M)(45.31M)
Pre-Tax Margin-138.4%-837.6%———
Income Tax Expense(8.04M)(688K)244K(32K)235K
Net Income(17.41M)(32.9M)(24.56M)(38.53M)(45.54M)
Net Margin-94.7%-820.4%———
EPS (Basic)(0.58)(1.08)(0.81)(1.26)(1.49)
EPS (Diluted)(0.58)(1.08)(0.81)(1.26)(1.49)
Weighted Avg Shares30.04M30.44M30.32M30.46M30.49M
Weighted Avg Shares (Diluted)30.04M30.44M30.44M30.46M30.49M

XBIT Earnings Waterfall · TTM

NASDAQ:XBIT · Revenue to Net Income

Key Ratios

EPS$-1.32
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-5.0
P/S Ratio0.0

Analysis

$0 of revenue converted into -$40.2M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-1.32, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipNov 13, 2026
10-QQuarterly reportNov 12, 2026
4Statement of changes in beneficial ownershipOct 28, 2026
3Initial statement of beneficial ownershipOct 28, 2026
4Statement of changes in beneficial ownershipOct 28, 2026

How much revenue does XBIT generate?

XBiotech Inc. (XBIT) reported $0.00 of revenue in fiscal 2025.

Is XBIT profitable?

XBiotech Inc. (XBIT) reported -$45.54M of net income.